On the other hand, fibroblast growth factor receptor 1 (FGFR1) is commonly expressed in all types of cancer and is involved in tumor progression and epithelial-to-mesenchymal transition-related drug resistance to EGFR-TKIs [184,185,186,187]. Here, FGFR1 is linked to neoplasm.